Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet
Back

A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet

Completed

Open to: ALL

Age: 12.0 - N/A

London London Oxford Sheffield Bradford Belfast

Medical Conditions

Celiac Disease

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


The main aim is to see how TAK-062 works to reduce celiac-related symptoms and improve small intestinal damage due to gluten exposure, in participants with celiac disease (CeD) attempting to maintain a gluten-free diet (GFD) in treated participants versus placebo controls.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Jun 2022 Nov 2024

INTERVENTIONAL

Intervention Type : DRUG
Intervention Description : TAK-062 tablets.

Intervention Arm Group : Cohort 1: TAK-062 Dose 1 + SIGE Gluten-Bar;Cohort 2: TAK-062 Dose 1 + Gluten-free SIGE Bar;Cohort 2: TAK-062 Dose 2 + Gluten-free SIGE Bar;Cohort 2: TAK-062 Dose 2 + SIGE Gluten-Bar;Cohort 2: TAK-062 Dose 3 + SIGE Gluten-Bar;

Intervention Type : DIETARY_SUPPLEMENT
Intervention Description : SIGE gluten bars.

Intervention Arm Group : Cohort 1: TAK-062 Dose 1 + SIGE Gluten-Bar;Cohort 1: TAK-062 Placebo + SIGE Gluten-Bar;Cohort 2: TAK-062 Dose 2 + SIGE Gluten-Bar;Cohort 2: TAK-062 Dose 3 + SIGE Gluten-Bar;Cohort 2: TAK-062 Placebo + SIGE Gluten-Bar;

Intervention Type : DRUG
Intervention Description : TAK-062 placebo-matching tablets.

Intervention Arm Group : Cohort 1: TAK-062 Placebo + SIGE Gluten-Bar;Cohort 2: TAK-062 Placebo + Gluten-free SIGE Bar;Cohort 2: TAK-062 Placebo + SIGE Gluten-Bar;

Intervention Type : DIETARY_SUPPLEMENT
Intervention Description : SIGE gluten-free bars.

Intervention Arm Group : Cohort 2: TAK-062 Dose 1 + Gluten-free SIGE Bar;Cohort 2: TAK-062 Dose 2 + Gluten-free SIGE Bar;Cohort 2: TAK-062 Placebo + Gluten-free SIGE Bar;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Royal London Hospital Dept of Gastroenterology
    London
    Greater London
    E1 1FR
  • King's College Hospital Dept of Gastroenterology
    London
    Greater London
    SE5 9RS
  • John Radcliffe Hospital Dept of Gastroenterology
    Oxford
    Oxfordshire
    OX3 9DU
  • Royal Hallamshire Hospital Dept of Gastroenterology
    Sheffield
    South Yorkshire
    S10 2JF
  • Bradford Teaching Hospitals NHS Foundation Trust
    Bradford
    West Yorkshire
    BD9 6RJ
  • The Ulster Hospital Department of Gastroenterology
    Belfast
    BT16 1RH


The study is sponsored by Takeda



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: NCT05353985
Last updated 01 August 2025

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top